دورية أكاديمية
Prenatal and infant antibiotic exposure and childhood growth, obesity and cardiovascular risk factors: The Rhea mother-child cohort study, Crete, Greece.
العنوان: | Prenatal and infant antibiotic exposure and childhood growth, obesity and cardiovascular risk factors: The Rhea mother-child cohort study, Crete, Greece. |
---|---|
المؤلفون: | Margetaki K; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.; Department of Preventive Medicine, Division of Environmental Health, University of Southern California, Los Angeles, California, USA., Stratakis N; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.; Department of Preventive Medicine, Division of Environmental Health, University of Southern California, Los Angeles, California, USA., Roumeliotaki T; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece., Karachaliou M; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece., Alexaki M; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece., Kogevinas M; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Centro de Investigación Biomédicaen Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Chatzi L; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.; Department of Preventive Medicine, Division of Environmental Health, University of Southern California, Los Angeles, California, USA., Vafeiadi M; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece. |
المصدر: | Pediatric obesity [Pediatr Obes] 2022 Jan; Vol. 17 (1), pp. e12843. Date of Electronic Publication: 2021 Aug 09. |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Blackwell for the International Association for the Study of Obesity Country of Publication: England NLM ID: 101572033 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-6310 (Electronic) Linking ISSN: 20476302 NLM ISO Abbreviation: Pediatr Obes Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Oxford, UK : Wiley-Blackwell for the International Association for the Study of Obesity |
مواضيع طبية MeSH: | Pediatric Obesity*/chemically induced , Pediatric Obesity*/epidemiology , Prenatal Exposure Delayed Effects*/chemically induced , Prenatal Exposure Delayed Effects*/epidemiology , Rheiformes*, Animals ; Anti-Bacterial Agents/adverse effects ; Body Mass Index ; Child ; Cohort Studies ; Female ; Greece/epidemiology ; Humans ; Infant ; Mother-Child Relations ; Pregnancy ; Risk Factors |
مستخلص: | Background: Early-life antibiotic use has been hypothesized to promote weight gain and increase the risk of childhood obesity. Objectives: To examine the associations of prenatal and infant antibiotics with childhood growth, adiposity and cardiometabolic traits in the Greek Rhea cohort. Methods: We used data from 747 mother-child pairs with anthropometric measurements drawn from medical records or measured at 4 and 6 years of age. Antibiotic exposure was assessed by maternal report during pregnancy and at the first year of life. Children were classified as exposed to antibiotics prenatally if the mother received at least one course of oral antibiotics during pregnancy and postnatally if the mother reported that the child received at least one oral antibiotic treatment during the first year of life. Outcomes included repeated weight, body mass index (BMI), waist circumference, body fat (%), total cholesterol and blood pressure. We applied mixed effects, linear and log-binomial regression models after adjusting for important covariates. Results: Around 14.6% of the participating children were prenatally exposed to antibiotics and 32.4% received antibiotics during the first year of life. Prenatal exposure to antibiotics was associated with a twofold increase in the risk for obesity (risk ratio [RR]; 95% confidence interval [CI]: 2.09 [1.58, 2.76]) and abdominal obesity (RR [95% CI]: 2.56 [1.89, 3.47]) at 6 years. Postnatal exposure to antibiotics was associated with increased weight (beta [95% CI]: 00.25 [0.06, 0.44]) and BMI (beta [95% CI]: 0.23 [0.003, 0.45]) SD scores from 2 to 7 years of life. Conclusion: Early-life antibiotic use was associated with accelerated childhood growth and higher adiposity. (© 2021 World Obesity Federation.) |
References: | de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92(5):1257-1264. Di Cesare M, Bentham J, Stevens GA, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377-1396. Tambalis KD, Panagiotakos D, Psarra G, Sidossis LS. Current data in Greek children indicate decreasing trends of obesity in the transition from childhood to adolescence; results from the national action for children's health (EYZHN) program. J Prev Med Hyg. 2018;59(1):E36. Singh AS, Mulder C, Twisk JWR, van Mechelen W, Chinapaw MJM. Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev. 2008;9(5):474-488. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes. 2012;36(1):1-11. Lichtveld K, Thomas K, Tulve NS. Chemical and non-chemical stressors affecting childhood obesity: a systematic scoping review. J Expo Sci Environ Epidemiol. 2018;28(1):1-12. Nogacka AM, Salazar N, Arboleya S, et al. Early microbiota, antibiotics and health. Cell Mol Life Sci. 2018;75(1):83-91. Martinez de Tejada B. Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health. 2014;11(8):7993-8009. Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H. High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the antibiotic resistance and prescribing in european children point prevalence survey. J Pediatric Infect Dis Soc. 2019;8(2):143-151. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3-12. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes. 2011;35(4):522-529. Murphy R, Stewart AW, Braithwaite I, Beasley R, Hancox RJ, Mitchell EA. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int J Obes. 2014;38(8):1115-1119. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes. 2013;37(1):16-23. Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes. 2014;38(10):1290-1298. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014;168(11):1063-1069. Gerber JS, Bryan M, Ross RK, et al. Antibiotic exposure during the first 6 months of life and weight gain during childhood. JAMA. 2016;315(12):1258-1265. Li DK, Chen H, Ferber J, Odouli R. Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study. Lancet Diabetes Endocrinol. 2017;5(1):18-25. Mbakwa CA, Scheres L, Penders J, Mommers M, Thijs C, Arts ICW. Early life antibiotic exposure and weight development in children. J Pediatr. 2016;176:105. Scott FI, Horton DB, Mamtani R, et al. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology. 2016;151(1):120. Poulsen MN, Pollak J, Bailey-Davis L, Hirsch AG, Glass TA, Schwartz BS. Associations of prenatal and childhood antibiotic use with child body mass index at age 3 years. Obesity. 2017;25(2):438-444. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135(4):617-626. Ville AP, Heyman MB, Medrano R, Wojcicki JM. Early antibiotic exposure and risk of childhood obesity in Latinos. Child Obes. 2017;13(3):231-235. Block JP, Bailey LC, Gillman MW, et al. Early antibiotic exposure and weight outcomes in young children. Pediatrics. 2018;142(6):e20180290. Dawson-Hahn EE, Rhee KE. The association between antibiotics in the first year of life and child growth trajectory. BMC Pediatr. 2019;19(1):23-32. Kelly D, Kelly A, O'Dowd T, Hayes CB. Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort. World J Pediatr. 2019;15(4):390-397. Leong KS, McLay J, Derraik JG, et al. Associations of prenatal and childhood antibiotic exposure with obesity at age 4 years. JAMA Netw Open. 2020;3(1):e1919681. Stark CM, Susi A, Emerick J, Nylund CM. Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut. 2019;68(1):62-69. Shao X, Ding X, Wang B, et al. Antibiotic exposure in early life increases risk of childhood obesity: a systematic review and meta-analysis. Front Endocrinol. 2017;8:170. Miller SA, Wu RKS, Oremus M. The association between antibiotic use in infancy and childhood overweight or obesity: a systematic review and meta-analysis. Obes Rev. 2018;19(11):1463-1475. Wan SR, Guo M, Zhang T, et al. Impact of exposure to antibiotics during pregnancy and infancy on childhood obesity: a systematic review and meta-analysis. Obesity. 2020;28(4):793-802. Mor A, Antonsen S, Kahlert J, et al. Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study. Int J Obes. 2015;39(10):1450-1455. Mueller NT, Whyatt R, Hoepner L, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes. 2015;39(4):665-670. Cassidy-Bushrow AE, Burmeister C, Havstad S, et al. Prenatal antimicrobial use and early-childhood body mass index. Int J Obes. 2018;42(1):1-7. Wang B, Liu J, Zhang Y, et al. Prenatal Exposure to Antibiotics and Risk of Childhood Obesity in a Multicenter Cohort Study. Am J Epidemiol. 2018;187(10):2159-2167. Heerman WJ, Daley MF, Boone-Heinonen J, et al. Maternal antibiotic use during pregnancy and childhood obesity at age 5 years. Int J Obes. 2019;43(6):1202-1209. Isaevska E, Popovic M, Pizzi C, et al. Maternal antibiotic use and vaginal infections in the third trimester of pregnancy and the risk of obesity in preschool children. Pediatr Obes. 2020;15(8):e12632. Jess T, Morgen CS, Harpsoe MC, et al. Antibiotic use during pregnancy and childhood overweight: a population-based nationwide cohort study. Sci Rep. 2019;9(1):11528. Li DK, Chen H, Ferber J, Odouli R. Maternal infection and antibiotic use in pregnancy and the risk of childhood obesity in offspring: a birth cohort study. Int J Obes. 2020;44(4):771-780. Lin M, Song H, Liu W, et al. Sex-specific associations between prenatal antibiotics exposure and offspring's body mass index. Int J Obes. 2020;44(10):2044-2051. Zhang MY, Differding MK, Benjamin-Neelon SE, Ostbye T, Hoyo C, Mueller NT. Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome. Ann Clin Microbiol Antimicrob. 2019;18(1):1-7. Hetherington-Rauth M, Bea JW, Lee VR, et al. Comparison of direct measures of adiposity with indirect measures for assessing cardiometabolic risk factors in preadolescent girls. Nutr J. 2017;16(1):15. Thompson DR, Obarzanek E, Franko DL, et al. Childhood overweight and cardiovascular disease risk factors: the national heart, lung, and blood institute growth and health study. J Pediatr. 2007;150(1):18-25. Freedman DS, Mei ZG, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa heart study. J Pediatr. 2007;150(1):12-17. Chatzi L, Leventakou V, Vafeiadi M, et al. Cohort profile: the mother-child cohort in Crete, Greece (Rhea Study). Int J Epidemiol. 2017;46(5):1392-1393k. WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76-85. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. B World Health Organ. 2007;85(9):660-667. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7(4):284-294. Linardakis M, Sarri K, Bertsias G, Papadaki A, Kafatos A. Waist circumference and waist-to-height percentiles for the youth of Crete, Greece. Int J Child Health Hum Dev. 2010;3(3):81-93. McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes. 2006;30(4):598-602. Gillman MW, Cook NR. Blood pressure measurement in childhood epidemiological studies. Circulation. 1995;92(4):1049-1057. Evans D, Chaix B, Lobbedez T, Verger C, Flahault A. Combining directed acyclic graphs and the change-in-estimate procedure as a novel approach to adjustment-variable selection in epidemiology. BMC Med Res Methodol. 2012;12(1):1-15. Rasmussen SH, Shrestha S, Bjerregaard LG, et al. Antibiotic exposure in early life and childhood overweight and obesity: a systematic review and meta-analysis. Diabetes Obes Metab. 2018;20(6):1508-1514. Campbell S, Tracey E, Fagan R, et al. Childhood infection, antibiotic exposure and subsequent metabolic risk in adolescent and young adult aboriginal Australians: practical implications. Aust J Prim Health. 2020;25(6):555-563. Lin J. Effect of antibiotic growth promoters on intestinal microbiota in food animals: a novel model for studying the relationship between gut microbiota and human obesity? Front Microbiol. 2011;2:53. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5(3):e9836. Stinson LF, Payne MS, Keelan JA. Planting the seed: origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit Rev Microbiol. 2017;43(3):352-369. Tilg H, Adolph TE. Influence of the human intestinal microbiome on obesity and metabolic dysfunction. Curr Opin Pediatr. 2015;27(4):496-501. Coates ME, Fuller R, Harrison GF, Lev M, Suffolk SF. A comparison of the growth of chicks in the Gustafsson germ-free apparatus and in a conventional environment, with and without dietary supplements of penicillin. Br J Nutr. 1963;17:141-150. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488(7413):621-626. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012;7(1):91-109. Marques FZ, Mackay CR, Kaye DM. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol. 2018;15(1):20-32. Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. Vidal AC, Murphy SK, Murtha AP, et al. Associations between antibiotic exposure during pregnancy, birthweight and aberrant methylation at imprinted genes among offspring. Int J Obes. 2013;37(7):907-913. Howe LD, Tilling K, Galobardes B, Lawlor DA. Loss to follow-up in cohort studies: bias in estimates of socioeconomic inequalities. Epidemiology. 2013;24(1):1. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46. |
فهرسة مساهمة: | Keywords: blood pressure; growth; obesity; postnatal antibiotics; prenatal antibiotics |
المشرفين على المادة: | 0 (Anti-Bacterial Agents) |
تواريخ الأحداث: | Date Created: 20210809 Date Completed: 20220110 Latest Revision: 20220110 |
رمز التحديث: | 20231215 |
DOI: | 10.1111/ijpo.12843 |
PMID: | 34369080 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!